IPCS INCHEM Home

International Agency for Research on Cancer (IARC) - Summaries & Evaluations

CINNAMYL ANTHRANILATE

VOL.: 16 (1978) (p. 287)

5. Summary of Data Reported and Evaluation

5.1 Animal data

In the only available study, cinnamyl anthranilate increased the incidence of lung tumours in mice following its intraperitoneal injection. These data are insufficient for an evaluation of the carcinogenicity of this compound to be made.

5.2 Human data

No case reports or epidemiological studies were available to the Working Group.

Subsequent evaluations: Vol. 31 (1983); Suppl. 7 (1987) (p. 60: Group 3); Vol. 77 (2000)

For definition of Groups, see Preamble Evaluation.

Last updated: 26 March 1998 






























    See Also:
       Toxicological Abbreviations
       Cinnamyl anthranilate (WHO Food Additives Series 16)
       CINNAMYL ANTHRANILATE (JECFA Evaluation)
       Cinnamyl Anthranilate (IARC Summary & Evaluation, Volume 31, 1983)
       Cinnamyl anthranilate  (IARC Summary & Evaluation, Volume 77, 2000)